title: Arginase levels and their association with Th17-related cytokines, soluble adhesion molecules (sICAM-1 and sVCAM-1) and hemolysis markers among steady-state sickle cell anemia patients.
abstract: Sickle cell anemia (SCA) is characterized by a marked endothelial dysfunction, owing to many factors. Arginine metabolism can be related to the inflammatory chronic state presented by patients, playing a key role in their clinical outcome and vascular endothelium. We investigated the serum arginase levels in 50 SCA patients (22 men and 28 women, mean age of 17 +/- 10.5 years) and 28 healthy controls. Serum arginase levels were associated with biochemical hemolysis markers and cytokines involved in Th17 response, as well as levels of soluble intercellular adhesion molecule-1 (sICAM-1) and vascular cell adhesion molecule-1 (sVCAM-1). Arginase concentrations were higher in SCA patients, compared with controls (p = 0.005), and were significantly and positively associated with total bilirubin (p = 0.004), indirect bilirubin (p = 0.04), and aspartate aminotransferase (AST; p = 0.039) in the SCA patient group. Moreover, arginase was significantly and positively associated with transforming growth factor-beta (TGF-beta; p = 0.008) among SCA patients. sICAM-1 was significantly and positively associated to reticulocytes (p = 0.014) and AST (p = 0.04). sVCAM-1 was likewise associated with lactate dehydrogenase (p = 0.03). These data suggest a new insight into arginase metabolism, as we show here a shift in arginine catabolism, where TGF-beta may induces the arginase pathway instead of the nitric oxide pathway and a possible involvement of the vascular activation and the serum arginase in chronic hemolysis among SCA patients. Additional studies should be carried out in order to investigate the mechanisms by which TGF-beta participates in the metabolism of arginase in SCA patients.
authors.affiliation: Centro de Pesquisas Gonçalo Moniz/FIOCRUZ, Rua Waldemar Falcão 121. Brotas, Salvador, Bahia, Brazil.
authors.forename: Wendell
authors.initials: W
authors.lastname: Vilas-Boas
authors.forename: Bruno A V
authors.initials: BA
authors.lastname: Cerqueira
authors.forename: Angela M D
authors.initials: AM
authors.lastname: Zanette
authors.forename: Mitermayer G
authors.initials: MG
authors.lastname: Reis
authors.forename: Manoel
authors.initials: M
authors.lastname: Barral-Netto
authors.forename: Marilda S
authors.initials: MS
authors.lastname: Goncalves
mesh_terms: D000293:Adolescent; D000328:Adult; D000755:Anemia, Sickle Cell / Q000097:blood* / Q000201:enzymology / Q000276:immunology; D001119:Arginase / Q000097:blood*; D015415:Biomarkers / Q000097:blood; D002648:Child; D016207:Cytokines / Q000097:blood; D005260:Female; D006461:Hemolysis / Q000276:immunology*; D006801:Humans; D018799:Intercellular Adhesion Molecule-1 / Q000097:blood*; D020381:Interleukin-17 / Q000097:blood*; D008297:Male; D012156:Reticulocytes / Q000378:metabolism / Q000473:pathology; D012995:Solubility; D006377:T-Lymphocytes, Helper-Inducer / Q000201:enzymology / Q000276:immunology / Q000378:metabolism*; D019010:Vascular Cell Adhesion Molecule-1 / Q000097:blood*; D055815:Young Adult
chemical_list: D015415:Biomarkers; D016207:Cytokines; D020381:Interleukin-17; D019010:Vascular Cell Adhesion Molecule-1; D018799:Intercellular Adhesion Molecule-1; D001119:Arginase
references.citation: Annu Rev Immunol. 1997;15:323-50
references.pmid: 9143691
references.citation: Hematology Am Soc Hematol Educ Program. 2005;:51-7
references.pmid: 16304359
references.citation: Hematology Am Soc Hematol Educ Program. 2007;:84-90
references.pmid: 18024614
references.citation: JAMA. 2005 Apr 6;293(13):1653-62
references.pmid: 15811985
references.citation: Lancet. 2002 Aug 24;360(9333):629-31
references.pmid: 12241949
references.citation: J Immunol. 2004 Jun 15;172(12):7565-73
references.pmid: 15187136
references.citation: Free Radic Biol Med. 2008 Apr 15;44(8):1506-28
references.pmid: 18261470
references.citation: J Am Soc Nephrol. 2004 Jan;15 Suppl 1:S55-7
references.pmid: 14684674
references.citation: Blood Rev. 2004 Mar;18(1):65-73
references.pmid: 14684149
references.citation: JAMA. 2005 Jul 6;294(1):81-90
references.pmid: 15998894
references.citation: Eur J Immunol. 1995 Apr;25(4):1101-4
references.pmid: 7537672
references.citation: Annu Rev Nutr. 2002;22:87-105
references.pmid: 12055339
references.citation: Microcirculation. 2004 Mar;11(2):129-51
references.pmid: 15280088
references.citation: Nephron. 2002 Apr;90(4):447-54
references.pmid: 11961404
references.citation: J Pediatr Hematol Oncol. 2000 Nov-Dec;22(6):515-20
references.pmid: 11132219
references.citation: Circulation. 2009 Mar 17;119(10):1424-32
references.pmid: 19255340
references.citation: J Exp Med. 2009 Sep 28;206(10):2067-77
references.pmid: 19737863
references.citation: J Immunol. 2017 Oct 1;199(7):2194-2201
references.pmid: 28923981
references.citation: Microcirculation. 2005 Jul-Aug;12(5):443-53
references.pmid: 16020392
references.citation: Br J Haematol. 2005 Nov;131(3):389-94
references.pmid: 16225659
references.citation: J Cell Biochem Suppl. 2002;38:88-95
references.pmid: 12046855
references.citation: J Immunol. 1998 Jun 1;160(11):5347-54
references.pmid: 9605134
references.citation: Am J Respir Crit Care Med. 2003 Jul 1;168(1):63-9
references.pmid: 12626350
references.citation: Curr Opin Immunol. 2007 Jun;19(3):281-6
references.pmid: 17433650
references.citation: Br J Haematol. 2000 Nov;111(2):498-500
references.pmid: 11122090
references.citation: Biochem Biophys Res Commun. 1995 Jan 17;206(2):667-73
references.pmid: 7530004